Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Korean Journal of Family Medicine ; : 40-42, 2017.
Artigo em Inglês | WPRIM | ID: wpr-109990

RESUMO

Escitalopram is a selective serotonin reuptake inhibitor antidepressant approved by the Food and Drug Administration for the treatment of major depressive disorder and generalized anxiety disorder. A 34-year-old female patient with major depressive disorder developed amenorrhea and had a false-positive urine pregnancy test after initiation of escitalopram treatment. To our knowledge, no published case report of amenorrhea and false-positive urine pregnancy tests in women taking escitalopram exists. This case report suggests that women of child-bearing age should be carefully monitored for amenorrhea while they are on an antidepressant treatment regimen.


Assuntos
Adulto , Feminino , Humanos , Gravidez , Gravidez , Amenorreia , Transtornos de Ansiedade , Citalopram , Transtorno Depressivo Maior , Hiperprolactinemia , Testes de Gravidez , Testes Imunológicos de Gravidez , Serotonina , Inibidores Seletivos de Recaptação de Serotonina , United States Food and Drug Administration
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA